EarlySign and Geisinger partner on AI-based detection of disease risk
Medial EarlySign has partnered with Geisinger and its Steele Institute for Health Innovation...
Focus:
-
![tuberculosis blood test]()
New blood test aims for smarter tuberculosis diagnosis
-
![infrared arthritis]()
Infrared light test offers fast, objective arthritis diagnosis
-
![early sepsis diagnosis]()
Wearable body patch allows early detection of sepsis
-
![mental health blood test]()
Start-up develops blood test for chronic pain and suicide risk
-
![modes of care hiv]()
HIV Testing Day: Bringing viral load assessment to primary care
-
![blood test ovarian cancer]()
Breakthrough biomarker blood test for ovarian cancer on the horizon
Most Read
Company A-Z
Latest Content
NSF’s Laurence Matheron and Robyn Meurant Take Part in MedFIT Panels
Two NSF medical device experts have taken part in panel discussions recently at the MedFIT conference in Lille, France.
MDNA Life Sciences launches new prostate cancer test in UK
Diagnostics developer MDNA Life Sciences has partnered with Aspire Pharma to introduce the new Mitomic Prostate Test (MPT) for clinical use in the UK.
Mindshare Medical gets CE-Mark for RevealAI-Lung
Mindshare Medical, a clinical decision support technologies developer, has received the European CE-Mark for the use of its RevealAI-Lung solution with computed tomography (CT) scans.
Japanese scientists use AI for early gastric cancer diagnosis
Scientists at Okayama University in Japan have developed an artificial intelligence (AI)-based endoscopic diagnosis system for the early identification of gastric cancer.
EarlySign and Geisinger partner on AI-based detection of disease risk
Medial EarlySign has partnered with Geisinger and its Steele Institute for Health Innovation to develop new machine learning-based solutions for the identification of people at risk of chronic and high-burden diseases.
New blood test aims for smarter tuberculosis diagnosis
A UK study has shown potential for a new blood test to diagnose human tuberculosis (TB) and identify those most at risk of developing the disease.
New technology analyses patient’s gaze to detect autism
A new technology developed by researchers at the University of Waterloo in Canada examines visual gaze in order to accurately diagnose autism spectrum disorder (ASD) in children.
Infrared light test offers fast, objective arthritis diagnosis
An infrared light test for rheumatoid arthritis (RA) developed by a research team at the University of Birmingham could offer a fast, objective way to diagnose and monitor the joint-attacking autoimmune condition.
Mylan HIV Self Test receives WHO prequalification approval
Pharmaceutical company Mylan and medical device maker Atomo Diagnostics have secured the World Health Organization (WHO) prequalification approval for an in-vitro HIV rapid diagnostic meant for self-testing.
Scientists discover autoimmune disease linked to testicular cancer
Scientists at Chan Zuckerberg (CZ) Biohub, Mayo Clinic and UC San Francisco have discovered an autoimmune disease that reportedly affects men with testicular cancer.
Latest News
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.
Close
Close
Close
Go Top
